Deprotonation of the complex [Cp 2 (CO) 3 Mo 2 (μ-η 2 -P 2 )(PPh 2 H)] ( 1 ) yields the anion [Cp 2 (CO) 3 Mo 2 (μ-η 2 -P 2 )(PPh 2 )] - ( 2 ). Reaction of 2 with cumulenes such as 3-ClC 6 H 4 NCO and PhNCS leads, after reprotonation, to the simple addition products [Cp 2 (CO) 3 Mo 2 (μ-η 2 -P 2 ){PPh 2 C( X)NHR}] (R = 3-ClPh, X = O, 4a; R = Ph, X = S, 4b ). Reaction of 2 with the Michael acceptors H 2 C C(H)R gives the related products [Cp 2 (CO) 3 Mo 2 (μ-η 2 -P 2 )(PPh 2 C 2 H 4 R)] (R = COOMe, 5a; R = CN, 5b; R = COMe, 5c ). In contrast, reaction of 2 with CS 2 followed by HBF 4 yields the complex [Cp 2 (CO) 3 Mo 2 (μ-η 3 -Ph 2 PC(H)SP 2 S)] ( 3 ), which has an unprecedented bridging ligand containing a CSP 2 S five-membered ring. Reaction of 3 with t BuLi followed by MeI yields [Cp 2 (CO) 3 Mo 2 (μ-η 2 -P 2 ){PPh 2 C(S)SMe}] ( 6 ), in which ring scission and re-formation of the tetrahedral Mo 2 P 2 core present in complex 1 has taken place. Reaction of 3 with metal carbonyls can also lead to re-formation of the Mo 2 P 2 moiety. The crystal structures of five of the new complexes have been determined.
No takes yet. Share an insight, caveat, or question.
Davies et al. (2000) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: